These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35397210)

  • 1. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
    BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
    Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
    BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in colorectal cancer incidence in seven high-income countries: a population-based study.
    Araghi M; Soerjomataram I; Bardot A; Ferlay J; Cabasag CJ; Morrison DS; De P; Tervonen H; Walsh PM; Bucher O; Engholm G; Jackson C; McClure C; Woods RR; Saint-Jacques N; Morgan E; Ransom D; Thursfield V; Møller B; Leonfellner S; Guren MG; Bray F; Arnold M
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):511-518. PubMed ID: 31105047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
    Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
    Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
    Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
    Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
    Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
    Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
    Vedsted P; Weller D; Zalounina Falborg A; Jensen H; Kalsi J; Brewster D; Lin Y; Gavin A; Barisic A; Grunfeld E; Lambe M; Malmberg M; Turner D; Harland E; Hawryluk B; Law RJ; Neal RD; White V; Bergin R; Harrison S; Menon U; ;
    BMJ Open; 2022 Dec; 12(12):e059669. PubMed ID: 36521881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
    Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
    Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
    Pilleron S; Charvat H; Araghi M; Arnold M; Fidler-Benaoudia MM; Bardot A; Grønlie Guren M; Tervonen H; Little A; O'Connell DL; Gavin A; De P; Aagard Thomsen L; Møller B; Jackson C; Bucher O; Walsh PM; Vernon S; Bray F; Soerjomataram I
    Int J Cancer; 2021 Apr; 148(7):1575-1585. PubMed ID: 33006395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Weller D; Falborg AZ; Jensen H; Butler J; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Fourkala EO; Gavin AT; Grunfeld E; Harland E; Kalsi J; Law RJ; Lin Y; Turner D; Neal RD; White V; Harrison S; Reguilon I; Lynch C; Vedsted P;
    Br J Cancer; 2022 Sep; 127(5):844-854. PubMed ID: 35618787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
    Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
    Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
    Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
    BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
    Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
    Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.